Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 3556
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00707746 | Safety and Efficacy Study of ISIS 301012 (Mipomersen) Administration in High Risk Statin Intolerant Subjects | ||
| NCT03955783 | Venetoclax and Selinexor in Treating Patients with Relapsed or Refractory High Risk Hematologic Malignancies | ||
| NCT04830137 | A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies | ||
| NCT02093403 | Decitabine and Selinexor in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia | ||
| NCT03398005 | A Phase 3 STudy of CaPRe In LOwering Very hiGh TriglYcerides (TRILOGY 1) | ||
| NCT01444729 | Post Approval Commitment Study | ||
| NCT05873595 | Real-World Data Study to Understand Effectiveness of Treatments in Peyronie's Disease | ||
| NCT06698939 | ORKA-001 in Healthy Volunteers | ||
| NCT05532696 | Phase 1b/2 Study to Evaluate ABT-101 in Solid Tumor and NSCLC Patients | ||
| NCT01555242 | A Study of Aneustat (OMN54) in Patients With Advanced Cancer and Lymphomas | ||
| NCT03970031 | A Study of MSDC-0602K to Assess Glycemic Control and Cardiovascular Outcomes in Patients With Pre-T2D or T2D and NAFLD/NASH | ||
| NCT03932513 | Evaluating the Effects of Inarigivir on Immune Response and Viral Markers in Chronic Hepatitis B Patients | ||
| NCT03514420 | Study of AKCEA-ANGPTL3-LRx (ISIS 703802) in Participants With Familial Partial Lipodystrophy (FPL) | ||
| NCT06313996 | A Study to Evaluate the Efficacy and Safety of Liso-cel Compared to Standard of Care in Adults With Relapsed or Refractory Follicular Lymphoma | ||
| NCT03226522 | Addressing Dementia Via Agitation-Centered Evaluation | ||
| NCT05401110 | Study of Osimertinib With Carotuximab in Advanced, EGFR-mutated Non-Small Cell Lung Cancer | ||
| NCT00757783 | Changes in Triglyceride and Other Lipids (Levels of Fats Found in Blood) When Taking Darunavir Compared to Atazanavir in HIV-infected Patients That Have Never Received Treatment | ||
| NCT02013154 | A Study of DKN-01 in Combination With Paclitaxel or Pembrolizumab | ||
| NCT04025502 | Event-Related Potential (ERP) Biomarkers in Subjects With Schizophrenia and Healthy Volunteer Subjects | ||
| NCT05789745 | A Study to Evaluate Plasma Gelsolin in Healthy Volunteers | ||
| NCT01775930 | Carfilzomib in Refractory Renal Cell Carcinoma (RCC) | ||
| NCT04661137 | A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multiple Myeloma | ||
| NCT02268851 | A Phase I/Ib Safety and Efficacy Study of the PI3K-delta Inhibitor TGR-1202 and Ibrutinib in Patients With CLL or MCL | ||
| NCT05103254 | Bempedoic Acid Pregnancy Surveillance Program | ||
| NCT03787602 | Navtemadlin (KRT-232) With or Without Anti-PD-1/Anti-PD-L1 for the Treatment of Patients With Merkel Cell Carcinoma | ||
| NCT01871402 | A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304) | ||
| NCT03631472 | Gala Early Feasibility Study of RheOx | ||
| NCT06641557 | A Phase I Dosing Study of IkT-148009. | ||
| NCT06220201 | A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2) | ||
| NCT05327530 | A Study of the Safety and Efficacy of Various Combinations of Avelumab as Therapy in Locally Advanced or Metastatic Urothelial Carcinoma (JAVELIN Bladder Medley) | ||
| NCT04621630 | Pharmacokinetics of PN-235 in Healthy Volunteers | ||
| NCT01657045 | Study to Evaluate the Safety and Efficacy of Dermal Injections of JVS-100 Given to Adults Receiving Median Sternotomy | ||
| NCT03936699 | ELIRA 2: Safety and Effectiveness of TENS Assisted Weight Loss and Appetite Suppression | ||
| NCT03769116 | A Randomized, Double-blind, Placebo-controlled Study of Delandistrogene Moxeparvovec (SRP-9001) for Duchenne Muscular Dystrophy (DMD) | ||
| NCT05639933 | Study to Investigate the Efficacy, Safety, and Tolerability of Topical HT-001 for the Treatment of Skin Toxicities Associated With Epidermal Growth Factor Receptor Inhibitors | ||
| NCT05304767 | An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia | ||
| NCT05511844 | Study of ORM-5029 in Subjects With HER2-Expressing Advanced Solid Tumors | ||
| NCT03299881 | Safety and Effectiveness of Transcutaneous Electrical Nerve Stimulation (TENS)-Assisted Weight Loss | ||
| NCT03455309 | Evaluation of NDV-3A Vaccine in Preventing S. Aureus Colonization | ||
| NCT03458416 | A Study to Assess the Long-Term Safety of Pharmaceutical Grade Synthetic Cannabidiol Oral Solution in Participants With Prader-Willi Syndrome | ||
| NCT01271998 | Pulmonary Disposition of TR-700 Following Once-Daily Oral 200 mg | ||
| NCT06568367 | Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN) | ||
| NCT06244992 | PTT-936 Alone or in Combination in Patients With Locally Advanced or Metastatic Solid Tumors | ||
| NCT01954030 | Phase 1/2 CTO + Bevacizumab for Recurrent Glioma Post-Bevacizumab Failure | ||
| NCT03012165 | A Study of ADX-102 in Subjects With Allergic Conjunctivitis | ||
| NCT04520607 | A Long-Term Safety and Efficacy Study of Lorecivivint in Subjects With Osteoarthritis of the Knee | ||
| NCT00914914 | Safety Study of a Cell Penetrating Peptide (p28) to Treat Solid Tumors That Resist Standard Methods of Treatment | ||
| NCT04819620 | Pharmacokinetics of PN-232 in Healthy Volunteers | ||
| NCT05869955 | A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1) | ||
| NCT04872608 | A Study of Letrozole, Palbociclib, and Onapristone ER in People With Metastatic Breast Cancer |
